BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23281008)

  • 21. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mouse model of accelerated liver aging caused by a defect in DNA repair.
    Gregg SQ; Gutiérrez V; Robinson AR; Woodell T; Nakao A; Ross MA; Michalopoulos GK; Rigatti L; Rothermel CE; Kamileri I; Garinis GA; Stolz DB; Niedernhofer LJ
    Hepatology; 2012 Feb; 55(2):609-21. PubMed ID: 21953681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.
    Wang L; Shi X; Zhao R; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
    Bone; 2010 May; 46(5):1369-79. PubMed ID: 19962460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NF-κB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells.
    Pengjam Y; Madhyastha H; Madhyastha R; Yamaguchi Y; Nakajima Y; Maruyama M
    Phytomedicine; 2016 Apr; 23(4):417-28. PubMed ID: 27002412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of interaction domains between human repair proteins ERCC1 and XPF.
    de Laat WL; Sijbers AM; Odijk H; Jaspers NG; Hoeijmakers JH
    Nucleic Acids Res; 1998 Sep; 26(18):4146-52. PubMed ID: 9722633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. USP45 deubiquitylase controls ERCC1-XPF endonuclease-mediated DNA damage responses.
    Perez-Oliva AB; Lachaud C; Szyniarowski P; Muñoz I; Macartney T; Hickson I; Rouse J; Alessi DR
    EMBO J; 2015 Feb; 34(3):326-43. PubMed ID: 25538220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERCC1-deficient cells and mice are hypersensitive to lipid peroxidation.
    Czerwińska J; Nowak M; Wojtczak P; Dziuban-Lech D; Cieśla JM; Kołata D; Gajewska B; Barańczyk-Kuźma A; Robinson AR; Shane HL; Gregg SQ; Rigatti LH; Yousefzadeh MJ; Gurkar AU; McGowan SJ; Kosicki K; Bednarek M; Zarakowska E; Gackowski D; Oliński R; Speina E; Niedernhofer LJ; Tudek B
    Free Radic Biol Med; 2018 Aug; 124():79-96. PubMed ID: 29860127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition.
    Yamaguchi M; Moore TW; Sun A; Snyder JP; Shoji M
    Integr Biol (Camb); 2012 Aug; 4(8):905-13. PubMed ID: 22751853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell autonomous and nonautonomous mechanisms drive hematopoietic stem/progenitor cell loss in the absence of DNA repair.
    Cho JS; Kook SH; Robinson AR; Niedernhofer LJ; Lee BC
    Stem Cells; 2013 Mar; 31(3):511-25. PubMed ID: 23097336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced hematopoietic reserves in DNA interstrand crosslink repair-deficient Ercc1-/- mice.
    Prasher JM; Lalai AS; Heijmans-Antonissen C; Ploemacher RE; Hoeijmakers JH; Touw IP; Niedernhofer LJ
    EMBO J; 2005 Feb; 24(4):861-71. PubMed ID: 15692571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.
    Hirayama T; Dai S; Abbas S; Yamanaka Y; Abu-Amer Y
    Arthritis Rheum; 2005 Sep; 52(9):2719-29. PubMed ID: 16142755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage.
    Aleyasin H; Cregan SP; Iyirhiaro G; O'Hare MJ; Callaghan SM; Slack RS; Park DS
    J Neurosci; 2004 Mar; 24(12):2963-73. PubMed ID: 15044535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The knock-down of ERCC1 but not of XPF causes multinucleation.
    Rageul J; Frëmin C; Ezan F; Baffet G; Langouët S
    DNA Repair (Amst); 2011 Sep; 10(9):978-90. PubMed ID: 21839691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
    Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
    Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells.
    Tsubaki M; Seki S; Takeda T; Chihara A; Arai Y; Morii Y; Imano M; Satou T; Shimomura K; Nishida S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.
    Lee JW; Iwahashi A; Hasegawa S; Yonezawa T; Jeon WB; Cha BY; Nagai K; Woo JT
    J Nat Med; 2012 Jan; 66(1):8-16. PubMed ID: 21656335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells.
    Heyza JR; Arora S; Zhang H; Conner KL; Lei W; Floyd AM; Deshmukh RR; Sarver J; Trabbic CJ; Erhardt P; Chan TH; Dou QP; Patrick SM
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.